1. Home
  2. SRI vs AVXL Comparison

SRI vs AVXL Comparison

Compare SRI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$6.22

Market Cap

205.1M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$1.52

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
AVXL
Founded
1965
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.1M
237.2M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
SRI
AVXL
Price
$6.22
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
155.1K
★ 1.1M
Earning Date
11-04-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $824,444,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.90
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 18.46
N/A
52 Week Low
$4.60
$1.44
52 Week High
$9.71
$9.50

Technical Indicators

Market Signals
Indicator
SRI
AVXL
Relative Strength Index (RSI) 29.33 19.35
Support Level $6.14 N/A
Resistance Level $7.51 $2.80
Average True Range (ATR) 0.22 0.13
MACD -0.05 -0.04
Stochastic Oscillator 4.40 7.57

Price Performance

Historical Comparison
SRI
AVXL

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: